Skyscape Web Viewer : EBMG : Cardiovascular Disease and Vascular Diseases : Primary Index

View All
Glomerular Filtration Rate Altered Dietary Salt Intake in Chronic Kidney Disease Antihypertensive Treatment for Kidney Transplant Recipients Combining ACE Inhibitors and Angiotensin Receptor Blockers in Renal Disease Gfr Calculator Interventions for Idiopathic Steroid-Resistant Nephrotic Syndrome in Children Optimal Serum Digoxin Concentration in Heart Failure Protein Restriction for Diabetic Kidney Disease Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease Statins for Improving Renal Outcomes What is Evidence-Based Medicine Guidelines
Glomerulonephritis, IgA
Glomerulonephritis
Glossalgia Burning Mouth and Glossalgia Burning Mouth and Glossalgia - Related Resources Cochrane review Hypersensitivity Hypersensitivity Mouth Mouth Nitrate Potassium Potassium Toothpaste
Glossitis
Gloves, Surgical
GLP-1 agonists
GLP-1 analogues
Glucagon-Like Peptide 1 GLP-1 Analogues for Weight Loss Among Patients with Type 2 Diabetes Incretin-Based Therapy with Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes
Glucagon-Like Peptides
Glucagon
Glucocorticoid injections Aseptic Bursitis of the Elbow Injection for Flexor Tenosynovitis Injection for Trigger Finger Injections Injections Joints Joints Local Glucocorticoid Injections in Soft Tissues and Joints Restricted Motion of the Shoulder; Intra-Articular Injection Restricted Motion of the Wrist in a Patient with Rheumatoid Arthritis
Glucocorticoid injection
Glucocorticoids
Glucocorticoid therapy Hereditary Angioedema (HAE) and ACE Inhibitor-Induced Angioedema Myopathies - Related Resources Treatment of Glucocorticoid-Induced Osteoporosis
Glucocorticoid treatment Pharmacological Glucocorticoid Treatment Treatment of Glucocorticoid-Induced Osteoporosis
Glucocorticosteroids
Glucocorticosteroid
Glucosamine
Glucose-based oral rehydration solution
Glucose-based oral rehydration therapy
Glucose control
Glucose homeostasis
Glucose Intolerance Gestational Diabetes Mellitus and Future Risk of Diabetes Prevention of Type 2 Diabetes in Persons at Increased Risk for the Development of T2d
Glucose-lowering Incretin-Based Therapy with Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes Insulin Added on Metformin in Type 2 Diabetes Metformin in the Treatment of Type II Diabetes Metformin Monotherapy for Type 2 Diabetes Mellitus Sglt-2 Inhibitors and GLP-1 Agonists for Diabetes and Chronic Kidney Disease Sulphonylurea for Type 2 Diabetes
Glucose lowering
Glucose Metabolism Disorders Gestational Diabetes Mellitus and Pregnancy Outcomes GLP-1 Analogues for Weight Loss Among Patients with Type 2 Diabetes Intensive Weight Management for Remission of Type 2 Diabetes Prevention of Type 2 Diabetes in Persons at Increased Risk for the Development of T2d
Biosimilar
Bioterrorism
BiPAP